J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 2,192.60
-22.55 (-1.02%)
At close: Jun 16, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 352.04 billion as of June 16, 2026. Its market cap has increased by 33.70% in one year.
Market Cap
352.04B
Enterprise Value
339.86B
Revenue
41.48B
Ranking
n/a
PE Ratio
49.33
Stock Price
2,192.60
Market Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 352.04B, an increase of 86,036.49%. That is a compound annual growth rate of 31.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 352.04B | 23.45% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.06T |
| Lupin | 1.05T |
| Abbott India | 558.26B |
| GlaxoSmithKline Pharmaceuticals | 359.26B |
| Rubicon Research | 213.43B |
| AstraZeneca Pharma India | 206.10B |
| Granules India | 189.84B |
| Caplin Point Laboratories | 183.29B |